AIM
CBPO

Acrospire Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Acrospire Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-184
Closed -$21K – 2047
2017
Q2 		$21K Buy
+184
New +$20.6K 0.02% 1510
2016
Q4 		– Sell
-284
Closed -$35K – 2578
2016
Q3 		$35K Buy
284
+100
+54% +$11.8K 0.02% 1274
2016
Q2 		$20K Sell
184
-100
-35% -$11.6K 0.01% 1534
2016
Q1 		$33K Buy
+284
New +$33.3K 0.02% 1261

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Acrospire Investment Management's CBPO Position: Q3 2017 in Review

Acrospire Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 184 shares — an estimated $21K sold.

Acrospire Investment Management first reported a position in CBPO in Q1 2016 and held it in 4 quarters. The position peaked at $35K in Q3 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Acrospire Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 184 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $21K.
  • Acrospire Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's China Biologic Products Holdings, Inc. position peaked at $35K in Q3 2016.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.